<?xml version="1.0" encoding="UTF-8"?>
<p id="Par23">Fifteen (15/20, 75.0%) patients completed three cycles and 5 (25.0%) completed two cycles of cisplatin. The recommended phase II dose was defined as famitinib 20Â mg/day with CCRT. Detailed treatments are presented in Additional file 
 <xref rid="MOESM1" ref-type="media">1</xref>: Table S2.
</p>
